Morgan Stanley reports 8% stake in Nuveen Core Plus
Morgan Stanley and Parametric Portfolio Associates LLC report a 2,290,571‑share position, representing 8.0% of Nuveen Core Plus Impact Fund’s common shares of beneficial interest as of 12/31/2025.
Rhea-AI Filing Summary
Morgan Stanley and Parametric Portfolio Associates LLC report a 2,290,571‑share position, representing 8.0% of Nuveen Core Plus Impact Fund’s common shares of beneficial interest as of 12/31/2025. The firms report shared voting power over 215,942 shares and shared dispositive power over 2,290,571 shares.
They certify the shares were acquired and are held in the ordinary course of business on a passive basis, not for changing or influencing control of the fund.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake do Morgan Stanley and Parametric hold in NPCT?
Who are the reporting persons in this NPCT Schedule 13G/A filing?
Is the NPCT stake reported as a passive investment?
As of what date are Morgan Stanley’s and Parametric’s NPCT holdings measured?
What type of filing did NPCT receive regarding this ownership disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.